ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.265
-0.02%
Bitcoin
67,801.68
-0.52%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Merck and Co Inc (MRK)

  7. Merck and Co Inc (MRK) News

MRK

Merck (MRK)

Merck and Co Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:MRK
DateTimeSourceHeadlineSymbolCompany
07/16/20246:45AMBusiness WireMerck to Share New Research and Host Community-Focused Symposia at AIDS 2024NYSE:MRKMerck and Co Inc
07/12/20246:45AMBusiness WireMerck Completes Acquisition of EyeBioNYSE:MRKMerck and Co Inc
07/09/20248:30AMBusiness WireMerck Animal Health Completes Acquisition of Elanco’s Aqua BusinessNYSE:MRKMerck and Co Inc
07/09/20248:28AMPR Newswire (US)Elanco Completes Sale of Aqua BusinessNYSE:MRKMerck and Co Inc
07/01/20248:15AMBusiness WireMerck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate CancerNYSE:MRKMerck and Co Inc
07/01/20246:45AMBusiness WireMerck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30NYSE:MRKMerck and Co Inc
06/28/20246:53AMBusiness WireMerck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)NYSE:MRKMerck and Co Inc
06/27/20248:18PMBusiness WireCDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate AdultsNYSE:MRKMerck and Co Inc
06/27/20247:13AMIH Market NewsInteractive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More NewsNYSE:MRKMerck and Co Inc
06/26/20247:45PMBusiness WirePatritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party ManufacturerNYSE:MRKMerck and Co Inc
06/25/20244:05PMBusiness WireUSDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine InfluenzaNYSE:MRKMerck and Co Inc
06/18/20247:02AMIH Market NewsFisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and MoreNYSE:MRKMerck and Co Inc
06/17/20245:29PMBusiness WireU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in AdultsNYSE:MRKMerck and Co Inc
06/17/20245:15PMBusiness WireFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial CarcinomaNYSE:MRKMerck and Co Inc
06/05/20246:45AMBusiness WireMerck to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:MRKMerck and Co Inc
06/04/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20242:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MRKMerck and Co Inc
06/04/20249:10AMIH Market NewsEconomic Worries May Lead To Weakness On Wall StreetNYSE:MRKMerck and Co Inc
05/30/20244:39PMEdgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNYSE:MRKMerck and Co Inc
05/30/20244:28PMEdgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NYSE:MRKMerck and Co Inc
05/30/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:MRKMerck and Co Inc
 Showing the most relevant articles for your search:NYSE:MRK

Your Recent History

USOTC
BIEL
Bioelectronics (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
COOP
Mr Cooper
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved